Current projects

Please select a project below to view more detail.

    2013

  1. NICE Implementation Collaborative Concordat
  2. Academy response to the Shape of training review
  3. Joint response to MHRA consultation on the revision of European legislation on medical devices
  4. Clinical trials and data disclosure
  5. Post-2015 MDG Framework
  6. Transposing the European Directive on animal research into UK law
  7. Future of the Human Fertilisation and Embryology Authority and the Human Tissue Authority

    8. 2012

  8. Treatments to avoid transmission of mitochondrial disease
  9. European Clinical Trials Regulation
  10. Team science: a discussion paper
  11. Academy letter to the Minister for Government Policy regarding the new Consultation Principles
  12. MHRA consultation on an early access to medicines scheme
  13. Global health partnerships and capacity building
  14. European Data Protection Regulation
  15. Transforming the regulation and governance of health research
  16. Joint Academies letter to the Prime Minister regarding the HoL Science and Technology Committee
  17. Strengthening Academic Psychiatry
  18. Joint Academies project on human enhancement and the future of work
  19. Academy contribution to the review of Liberal Democrat Science Policy
  20. Stratified medicines

    21. 2011

  21. Academy response to Government life sciences commitments
  22. Update: Use of non-human primates in research
  23. Animals containing human material
  24. Revision of the EU Clinical Trials Directive 2001/20/EC
  25. A new pathway for the regulation and governance of health research
*
*

Stratified medicines

Summary

Summary:

The Academy is continuing our work to facilitate progress in stratified medicines research and development, and its implementation in healthcare services. 

Significant recent investment has been made into the development of stratified medicines apporaches, and initiatives to co-ordinate work across UK organisations, including the Technology Strategy Board’s 'Stratified Medicine Innovation Platform' are now in place.

The Academy is currently developing a programme focusing on the ongoing regulatory, economic, and infrastructure requirements of stratified medicines approaches in the UK.

Further details of the Academy's previous work, and the 2008 'Optimizing stratified medicines R&D: addressing scientific and economic issues' report are available here.

For futher information please contact Naho.Yamazaki@acmedsci.ac.uk

back to top

*
*
    Back to:
  1. Policy